Gene Query: UNC13D

Dataset Description Geneva Score
NR2F2 study 91.44
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 91.44
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 91.31
Total RNA-seq in ALL-SIL upon JQ1 inhibition 83.48
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 78.76
Nutritional control of protein translation 69.62
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 60.89
Inhibition of TNBC metastasis by Gpx1 60.26
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 57.79
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 57.74
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 55.96
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 55.96
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 46.01
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 45.6
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 45.6
Ebola virus (EBOV) infection of ARPE-19 cells 44.88
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 42.93
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 42.93
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 41.31
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 41.31
RNA-seq analysis of AML cells in response to ASLAN003 39.78
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 39.08
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 39.08
Genome wide expression change by RNF168 knocking down in NEC cells 39.04
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 38.54
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 38.54
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 36.58
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 36.58
RNA-Seq analysis of breast cancer cells after shikonin treatment 35.32
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 34.7
RNA-seq analysis to identify the genes regulated by p53-SET interplay 34.51
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 34.2
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 33.83
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 33.83
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 33.81
hTERT promotes cell adhesion and migration independent of telomerase activity 33.17
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 32.24
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 32.16
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 30.25
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 30.25
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 29.61
RNA-seq of cells with TET1 knockout 29.5
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 29.44
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 29.05
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 29.05
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 29.04
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 28.96
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 28.44
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 28.08
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 27.64
Fbxo32 mediated gene expression program underlies EMT and metastasis 27.53
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 27.38
MEIS1 regulates hematopoiesis in hPSCs 27.21
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 27.1
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 26.76
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 26.63
Accurate annotation of human protein-coding small open reading frames 26.21
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 26.17
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 25.69
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 25.38
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 24.26
Ro60-knockout cells 23.36
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 23.31
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 23.18
A role for ZNF598 in post-transcriptional gene regulation 23.12
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 22.66
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 22.66
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 22.42
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 21.37
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 21.16
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 20.81
SUV420H2 knockdown in PANC-1 20.55
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 20.45
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 20.0
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 20.0
Pharmacologic inhibition of STAT5 in AML 19.98
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 19.76
Gene expression changes associated with resistance to tagraxofusp (SL-401) 19.62
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 19.59
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 19.53
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 19.53
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 19.38
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 19.32
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 19.29
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 18.73
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 18.59
Transciptomic profiling of human fetal lung samples 18.54
RNAseq of T-ALL upon long non coding rna purturbation 18.42
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 18.34
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 18.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 18.12
Global analysis of alternative splicing regulated by RBM10 18.08
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 17.97
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 17.94
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 17.84
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 17.83
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 17.81
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 17.73
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 17.73
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 17.63
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 17.61
Patient-derived luminal breast cancer xenografts with progestins 17.61
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 17.61
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 17.5
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 17.46
RNA sequencing of human pancreatic cancer cell lines 17.04
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 16.93
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 16.87
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 16.79
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 16.78
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 16.76
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 16.76
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 16.59
Comparing gene expression in iPSC derived RPE from control and AMD donors 16.43
Spliceosomal disruption of the non-canonical BAF complex in cancer 16.41
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 16.01
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 15.98
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 15.98
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 15.93
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 15.77
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 15.75
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 15.38
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 15.25
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 15.25
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 15.08
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 14.71
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 14.56
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 14.42
Gene expression analysis of immortalized human liver progenitor-like cells in culture 14.37
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 14.25
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 14.25
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 14.23
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 14.2
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 14.0
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 13.99
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 13.99
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 13.94
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 13.91
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 13.91
Intrahepatic MAIT cell gene expression revealed by RNA-seq 13.77
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 13.75
Irf9 function in immunity in mouse 13.75
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 13.38
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 13.37
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 13.37
MCF-7 as a model for functional analysis of breast cancer risk variants 13.32
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 13.18
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 13.06
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 13.06
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 13.05
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 12.95
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 12.95
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 12.92
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 12.79
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 12.75
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 12.62
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 12.54
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 12.36
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 12.33
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 12.19
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 12.19
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 12.17
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 12.08
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 12.01
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 12.0
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 11.98
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 11.73
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 11.71
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 11.71
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 11.68
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 11.64
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 11.63
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 11.59
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 11.59
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 11.58
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 11.5
Regulation of highly expressed hCINAP on translatome 11.48
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 11.48
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 11.47
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 11.45
RNA seq comparison between scrambled and shGRP78 cells 11.36
hnRNP C is a key regulator of protein synthesis in mitosis 11.32
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 11.21
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 11.19
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 11.15
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 11.15
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 11.13
RNA-seq analysis of control and Myc-induced U2OS cells 11.12
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 11.05
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.98
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.98
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 10.94
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 10.92
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 10.89
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 10.85
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 10.85
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 10.84
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 10.83
Transcriptome of activated human and mouse MAIT cells 10.81
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 10.7
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 10.69
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 10.65
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 10.52
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 10.52
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 10.49
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 10.35
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 10.29
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 10.29
The cohesin complex prevents Myc-induced replication stress 10.18
Stem and effector CD8 T-cells from human cancers 10.11
Genome wide expression change in LCC2 and MCF-7 cells 10.11
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 10.09
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 9.84
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 9.82
MCF10A H-Ras RNA-Seq 9.81
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 9.76
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 9.72
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 9.7
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 9.7
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 9.68
Human neutrophil genome during PMA- and E. coli encounter-induced activation 9.65
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 9.65
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 9.6
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 9.59
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 9.54
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 9.54
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 9.48
RNA-Sequencing of HepG2 cells treated with TGFBeta 9.45
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 9.41
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 9.41
Crizotinib v. DMSO in SW480 cells 9.36
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 9.31
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 9.28
Developmental stage specific chromosome architecture in human erythroid cells 9.28
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 9.27
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.27
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 9.17
A novel target of EZH1/2 for treatment of mantle cell lymphoma 9.16
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 9.13
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 9.11
Transcriptome analysis of virus infected tissues 9.01
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 9.0
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 8.98
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 8.94
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 8.92
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 8.88
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.86
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 8.72
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 8.69
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 8.69
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.67
Transcriptome analysis reveals differential splicing events in IPF lung tissue 8.64
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 8.64
PTHrP overexpression in MCF7 cells 8.62
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 8.5
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 8.48
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 8.45
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 8.45
Primary human trophoblast from term placenta 8.44
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 8.43
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 8.43
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 8.42
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 8.38
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 8.33
Solid phase chemistry to covalently and reversibly capture thiolated RNA 8.26
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 8.22
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 8.22
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 8.19
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 8.19
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 8.18
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 8.17
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.16
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.16
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 8.1
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.09
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 8.04
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 8.01
Targeting MTHFD2 in Acute Myeloid Leukemia 7.88
RNA sequencing of primary human platelets and in vitro cell lines 7.86
A549 cells and MSR-A549 cells 7.85
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 7.85
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 7.82
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 7.71
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 7.65
RNA expression analysis upon JMJD1C depletion 7.56
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 7.56
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 7.51
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 7.51
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 7.42
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 7.41
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 7.39
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 7.36
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 7.35
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 7.31
Genome-wide discovery of human splicing branchpoints 7.3
Nucleoporin-mediated regulation of cell identity genes 7.3
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 7.28
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 7.22
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 7.21
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 7.18
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 7.06
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.99
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.99
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 6.96
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 6.85
The effect of Abl kinases on non-small cell carcinoma global transcriptome 6.77
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 6.71
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 6.63
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 6.6
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 6.53
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 6.43
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 6.33
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.32
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 6.31
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.29
Transcriptome analysis of human lung epithelial cells 6.28
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.27
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 6.27
Gene expression profile of human placenta from T. Cruzi infected mothers 6.26
circRNA profile in hypopharyngeal cancer 6.19
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 6.18
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 6.18
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 6.13
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 6.07
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.99
Genome-wide discovery of human splicing branchpoints [RNAse] 5.96
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 5.94
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 5.92
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 5.82
The cytokine environment influence on human skin-derived T cells 5.74
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 5.74
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 5.69
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 5.68
Fusion discovery in breast cancer cell line 5.64
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 5.56
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.54
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.54
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.51
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 5.49
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 5.49
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 5.42
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 5.4
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  5.32
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 5.31
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 5.27
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 5.27
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 5.22
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 5.2
Gene expression analysis of human liver progenitor-like cells in culture 5.19
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.12
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.1
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 5.07
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 5.06
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 5.05
Gene expression analysis of breast cancer cell-lines 5.0
Gene expression and genome-wide location analysis of breast cancer cell-lines 5.0
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 4.95
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.9
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 4.77
TAF1 is critical for AE driven leukemogenesis 4.77
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 4.73
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 4.67
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 4.58
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 4.58
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 4.55
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 4.55
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.49
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 4.44
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.4
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.36
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.36
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 4.24
Human ovarian granulosa cell transcriptome 4.23
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 4.21
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 4.16
Transcriptomic profiling of human peripheral blood-derived mast cells 4.16
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 4.13
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 4.13
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 4.12
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 4.12
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 4.09
Gene expression of thyroid cancer cell lines 4.06
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 3.86
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 3.81
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.74
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 3.63
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 3.47
H1609088 Human RNA-Sequencing 3.45
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 3.41
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 3.4
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 3.4
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 3.39
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 3.39
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.31
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 3.31
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 3.31
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.27
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 3.24
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 3.21
Capturing the Interactome of Newly Transcribed RNA 3.18
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.18
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 3.17
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 3.11
Transcriptomes in healthy and CHB fetal hearts 3.09
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 3.08
Illumina Total RNA-seq in HeLa 3.06
RNA seq analysis of human Fetal and adult derived Enterospheres 2.86
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.81
RNA-Seq of Breast and Ovarian Cancer Cell Lines 2.77
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 2.75
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 2.75
RNA-seq of cancer cell lines treated with T-025 2.7
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 2.7
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.63
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.62
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.62
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.59
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.59
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 2.55
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 2.5
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.49
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.48
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.44
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.44
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.37
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 2.31
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 2.28
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.24
ML29755 RNA-seq data 2.23
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 2.11
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 2.1
RNA-Seq analysis of human colorectal cancer with liver metastasis 2.1
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.09
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.09
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.03
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.93
RNA-Seq and expression data from human adipose tissue 1.89
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.89
Deep RNA sequencing of the human placental transcriptome 1.89
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.87
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.82
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 1.82
Gene expression profile in breast cancer cell lines using RNA sequencing 1.72
mRNA sequencing of oropharyngeal cancer cell lines 1.7
A practical evaluation of alignment algorithms for RNA variant calling analysis 1.69
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.61
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.61
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.57
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.54
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 1.49
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 1.49
Transcriptome of EBV-infected gastric cancer cell lines 1.48
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.45
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.45
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.37
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.35
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.35
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.27
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.24
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.24
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.24
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.16
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.09
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.02
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.02
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.01
Gene expression analysis in response to hypoxic pathway inhibition 0.99
Gene expression profile of CRC-derived HILEC 0.97
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.94
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.92
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.85
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.76
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.76
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.76
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.75
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.74
Impact on erythroid progenitor type on erythroid differntiation 0.69
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.67
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.65
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.61
JAK dependent survival of ALK- ALCL 0.51
The role of m6A/m-RNA methylation in stress response regulation 0.44
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.44
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.38
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 0.37
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.34
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.34
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.32
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.27
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.27
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.21
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.19
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.14
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.07
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.07
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.07
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.06
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.05
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.03
MHC Transcriptomic landscape at haplotype-specific resolution 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation